OVID THERAPEUTICS INC.

Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights

08 نوفمبر 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference

27 سبتمبر 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

07 سبتمبر 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights

09 أغسطس 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Presents Preclinical Data on OV329 at the Epilepsy Foundation Pipeline Conference

06 يونيو 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights

10 مايو 2022 08:00:04 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

08 أبريل 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial Results

15 مارس 2022 08:00:03 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference

04 مارس 2022 08:00:00 بحسب Nasdaq GlobeNewswire

Healx and Ovid Therapeutics to Enter Strategic Partnership

08 فبراير 2022 08:00:03 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators

03 يناير 2022 06:30:00 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Reports Third Quarter 2021 Business Update, Corporate Highlights and Financial Results

10 نوفمبر 2021 08:30:00 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Appoints Dr. Kevin Fitzgerald to Board of Directors

07 أكتوبر 2021 08:30:00 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

07 سبتمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Highlights

16 أغسطس 2021 08:00:02 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Strengthens Board & Leadership Team to Focus Efforts on Expanding Its Neurosciences Capabilities

08 يوليو 2021 16:30:00 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference

07 يوليو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Appoints Jeff Rona as Chief Business and Financial Officer

04 يونيو 2021 08:00:00 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Appoints Dr. Joy A. Cavagnaro and Dr. Bruce A. Sullenger to its Scientific Advisory Board

26 مايو 2021 08:00:02 بحسب Nasdaq GlobeNewswire

Ovid Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

13 مايو 2021 16:05:01 بحسب Nasdaq GlobeNewswire